Literature DB >> 20463584

Immune exhaustion occurs concomitantly with immune activation and decrease in regulatory T cells in viremic chronically HIV-1-infected patients.

Meenakshi Sachdeva1, Margaret A Fischl, Rajendra Pahwa, Naresh Sachdeva, Savita Pahwa.   

Abstract

BACKGROUND: Chronic HIV-1 infection is associated with excessive immune activation and immune exhaustion. We investigated the relationship of these 2 phenotypes and frequency of regulatory T cells (Tregs) in controlled and uncontrolled chronic HIV-1 infection.
METHODS: Immune exhaustion marker PD-1, its ligand PD-L1, CD4CD25 FoxP3 Tregs, HLA-DR, and CD38 coexpression as activation markers were investigated in peripheral blood lymphocytes of 44 HIV-1-infected patients and 11 HIV-1-uninfected controls by multicolor flow cytometry.
RESULTS: Activated and PD-1 expressing T cells were increased, and Tregs were decreased in HIV-1-infected patients as compared with controls, and alterations were greatest in viremic patients. The proportion of activated CD8 T cells exceeded activated CD4 T cells. Tregs had an inverse correlation with activated T cells and PD-1 expressing T cells. PD-L1 was highly expressed on monocytes and to a lesser extent on T lymphocytes of patients. These abnormalities partially reversed with virologic control after potent antiretroviral therapy.
CONCLUSIONS: Immune exhaustion is a component of aberrant immune activation in chronic HIV-1 infection and is associated with loss of Tregs and ongoing virus replication. These defects are corrected partially with effective virologic control by potent antiretroviral therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20463584      PMCID: PMC3095513          DOI: 10.1097/QAI.0b013e3181e0c7d0

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  35 in total

Review 1.  The B7-CD28 superfamily.

Authors:  Arlene H Sharpe; Gordon J Freeman
Journal:  Nat Rev Immunol       Date:  2002-02       Impact factor: 53.106

2.  B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression.

Authors:  Daria Trabattoni; Marina Saresella; Mara Biasin; Adriano Boasso; Luca Piacentini; Pasquale Ferrante; Haidong Dong; Renato Maserati; Gene M Shearer; Lieping Chen; Mario Clerici
Journal:  Blood       Date:  2002-12-05       Impact factor: 22.113

3.  Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses.

Authors:  Spencer C Liang; Yvette E Latchman; Janet E Buhlmann; Michal F Tomczak; Bruce H Horwitz; Gordon J Freeman; Arlene H Sharpe
Journal:  Eur J Immunol       Date:  2003-10       Impact factor: 5.532

4.  Upregulation of PD-L1 on monocytes and dendritic cells by HIV-1 derived TLR ligands.

Authors:  Angela Meier; Aranya Bagchi; Harlyn K Sidhu; Galit Alter; Todd J Suscovich; Daniel G Kavanagh; Hendrik Streeck; Mark A Brockman; Sylvie LeGall; Judith Hellman; Marcus Altfeld
Journal:  AIDS       Date:  2008-03-12       Impact factor: 4.177

5.  4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function.

Authors:  Tao Wen; Jacob Bukczynski; Tania H Watts
Journal:  J Immunol       Date:  2002-05-15       Impact factor: 5.422

6.  Expression of programmed death 1 ligands by murine T cells and APC.

Authors:  Tomohide Yamazaki; Hisaya Akiba; Hideyuki Iwai; Hironori Matsuda; Mami Aoki; Yuka Tanno; Tahiro Shin; Haruo Tsuchiya; Drew M Pardoll; Ko Okumura; Miyuki Azuma; Hideo Yagita
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

7.  Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy.

Authors:  Giulia Marchetti; Giusi M Bellistrì; Elisa Borghi; Camilla Tincati; Stefania Ferramosca; Maria La Francesca; Giulia Morace; Andrea Gori; Antonella D'Arminio Monforte
Journal:  AIDS       Date:  2008-10-01       Impact factor: 4.177

8.  Decreased immune activation in resistance to HIV-1 infection is associated with an elevated frequency of CD4(+)CD25(+)FOXP3(+) regulatory T cells.

Authors:  Catherine M Card; Paul J McLaren; Charles Wachihi; Joshua Kimani; Francis A Plummer; Keith R Fowke
Journal:  J Infect Dis       Date:  2009-05-01       Impact factor: 5.226

9.  Differential association of programmed death-1 and CD57 with ex vivo survival of CD8+ T cells in HIV infection.

Authors:  Constantinos Petrovas; Benjamin Chaon; David R Ambrozak; David A Price; J Joseph Melenhorst; Brenna J Hill; Christof Geldmacher; Joseph P Casazza; Pratip K Chattopadhyay; Mario Roederer; Daniel C Douek; Yvonne M Mueller; Jeffrey M Jacobson; Viraj Kulkarni; Barbara K Felber; George N Pavlakis; Peter D Katsikis; Richard A Koup
Journal:  J Immunol       Date:  2009-06-29       Impact factor: 5.422

10.  Microbial translocation is a cause of systemic immune activation in chronic HIV infection.

Authors:  Jason M Brenchley; David A Price; Timothy W Schacker; Tedi E Asher; Guido Silvestri; Srinivas Rao; Zachary Kazzaz; Ethan Bornstein; Olivier Lambotte; Daniel Altmann; Bruce R Blazar; Benigno Rodriguez; Leia Teixeira-Johnson; Alan Landay; Jeffrey N Martin; Frederick M Hecht; Louis J Picker; Michael M Lederman; Steven G Deeks; Daniel C Douek
Journal:  Nat Med       Date:  2006-11-19       Impact factor: 53.440

View more
  41 in total

Review 1.  Revisiting immune exhaustion during HIV infection.

Authors:  Alka Khaitan; Derya Unutmaz
Journal:  Curr HIV/AIDS Rep       Date:  2011-03       Impact factor: 5.071

2.  Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection.

Authors:  Tricia H Burdo; Allison Weiffenbach; Steven P Woods; Scott Letendre; Ronald J Ellis; Kenneth C Williams
Journal:  AIDS       Date:  2013-06-01       Impact factor: 4.177

3.  Acting locally: innate mucosal immunity in resistance to HIV-1 infection in Kenyan commercial sex workers.

Authors:  X-D Yao; R W Omange; B M Henrick; R T Lester; J Kimani; T B Ball; F A Plummer; K L Rosenthal
Journal:  Mucosal Immunol       Date:  2013-06-26       Impact factor: 7.313

4.  4-1BB signaling synergizes with programmed death ligand 1 blockade to augment CD8 T cell responses during chronic viral infection.

Authors:  Vaiva Vezys; Pablo Penaloza-MacMaster; Daniel L Barber; Sang-Jun Ha; Bogumila Konieczny; Gordon J Freeman; Robert S Mittler; Rafi Ahmed
Journal:  J Immunol       Date:  2011-07-08       Impact factor: 5.422

5.  Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy.

Authors:  Tricia H Burdo; Margaret R Lentz; Patrick Autissier; Anitha Krishnan; Elkan Halpern; Scott Letendre; Eric S Rosenberg; Ronald J Ellis; Kenneth C Williams
Journal:  J Infect Dis       Date:  2011-07-01       Impact factor: 5.226

6.  Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy.

Authors:  Cynthia L Gay; Ronald J Bosch; Justin Ritz; Jason M Hataye; Evgenia Aga; Randall L Tressler; Stephen W Mason; Carey K Hwang; Dennis M Grasela; Neelanjana Ray; Josh C Cyktor; John M Coffin; Edward P Acosta; Richard A Koup; John W Mellors; Joseph J Eron
Journal:  J Infect Dis       Date:  2017-06-01       Impact factor: 5.226

7.  Increased Immune Activation and Exhaustion in HIV-infected Youth.

Authors:  Allison Ross Eckard; Julia C Rosebush; S Thera Lee; Mary Ann O'Riordan; Jakob G Habib; Julie E Daniels; Danielle Labbato; Monika Uribe-Leitz; Ann Chahroudi; Grace A McComsey
Journal:  Pediatr Infect Dis J       Date:  2016-12       Impact factor: 2.129

8.  Association between discordant immunological response to highly active anti-retroviral therapy, regulatory T cell percentage, immune cell activation and very low-level viraemia in HIV-infected patients.

Authors:  J Saison; T Ferry; J Demaret; D Maucort Boulch; F Venet; T Perpoint; F Ader; V Icard; C Chidiac; G Monneret
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

9.  Role of interferon-γ and cytotoxic T lymphocytes in intraocular tumor rejection.

Authors:  Ann J Ligocki; Joseph R Brown; Jerry Y Niederkorn
Journal:  J Leukoc Biol       Date:  2015-11-17       Impact factor: 4.962

Review 10.  Foxo3a: an integrator of immune dysfunction during HIV infection.

Authors:  Julien van Grevenynghe; Rafael A Cubas; Sandrina DaFonseca; Talibah Metcalf; Cecile L Tremblay; Lydie Trautmann; Rafick-Pierre Sekaly; John Schatzle; Elias K Haddad
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-27       Impact factor: 7.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.